These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 27533749)

  • 1. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn's disease: a systematic review and meta-analysis.
    Wang X; Qin L; Cao J; Zhao J
    Curr Med Res Opin; 2016 Dec; 32(12):2007-2012. PubMed ID: 27533749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
    Vermeire S; Louis E; Rutgeerts P; De Vos M; Van Gossum A; Belaiche J; Pescatore P; Fiasse R; Pelckmans P; Vlietinck R; Merlin F; Zouali H; Thomas G; Colombel JF; Hugot JP;
    Gastroenterology; 2002 Jul; 123(1):106-11. PubMed ID: 12105838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TNF-alpha loss of response is associated with a decreased percentage of FoxP3+ T cells and a variant NOD2 genotype in patients with Crohn's disease.
    Juanola O; Moratalla A; Gutiérrez A; Sempere L; Zapater P; Giménez P; Almenta I; Peiró G; González-Navajas JM; Such JF; Francés R
    J Gastroenterol; 2015 Jul; 50(7):758-68. PubMed ID: 25500977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD2, CD14 and TLR4 mutations do not influence response to adalimumab in patients with Crohn's disease: a preliminary report.
    Barreiro-de Acosta M; Ouburg S; Morré SA; Crusius JB; Lorenzo A; Potel J; Salvador-Peña A; Domínguez-Muñoz JE
    Rev Esp Enferm Dig; 2010 Oct; 102(10):591-5. PubMed ID: 21039068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease genotypes of patients in remission vs relapses after infliximab discontinuation.
    Lu C; Waugh A; Bailey RJ; Cherry R; Dieleman LA; Gramlich L; Matic K; Millan M; Kroeker KI; Sadowski D; Teshima CW; Todoruk D; Wong C; Wong K; Fedorak RN
    World J Gastroenterol; 2012 Sep; 18(36):5058-64. PubMed ID: 23049214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to medical treatment in patients with Crohn's disease: the role of NOD2/CRAD15, disease phenotype, and age of diagnosis.
    Weiss B; Lebowitz O; Fidder HH; Maza I; Levine A; Shaoul R; Reif S; Bujanover Y; Karban A
    Dig Dis Sci; 2010 Jun; 55(6):1674-80. PubMed ID: 19693669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease.
    Behm BW; Bickston SJ
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006893. PubMed ID: 18254120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IBD5 polymorphisms in inflammatory bowel disease: association with response to infliximab.
    Urcelay E; Mendoza JL; Martinez A; Fernandez L; Taxonera C; Diaz-Rubio M; de la Concha EG
    World J Gastroenterol; 2005 Feb; 11(8):1187-92. PubMed ID: 15754402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CARD15/NOD2, CD14 and toll-like 4 receptor gene polymorphisms in Saudi patients with Crohn's Disease.
    Azzam N; Nounou H; Alharbi O; Aljebreen A; Shalaby M
    Int J Mol Sci; 2012; 13(4):4268-4280. PubMed ID: 22605977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype.
    Glas J; Török HP; Tonenchi L; Kapser J; Schiemann U; Müller-Myhsok B; Folwaczny M; Folwaczny C
    Inflamm Bowel Dis; 2005 Dec; 11(12):1031-7. PubMed ID: 16306764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crohn's disease patients carrying Nod2/CARD15 gene variants have an increased and early need for first surgery due to stricturing disease and higher rate of surgical recurrence.
    Alvarez-Lobos M; Arostegui JI; Sans M; Tassies D; Plaza S; Delgado S; Lacy AM; Pique JM; Yagüe J; Panés J
    Ann Surg; 2005 Nov; 242(5):693-700. PubMed ID: 16244543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NOD2/CARD15 mutations in Croatian patients with Crohn's disease: prevalence and genotype-phenotype relationship.
    Cukovic-Cavka S; Vermeire S; Hrstic I; Claessens G; Kolacek S; Jakic-Razumovic J; Krznaric Z; Grubelic K; Radic D; Misak Z; Jadresin O; Rutgeerts P; Vucelic B
    Eur J Gastroenterol Hepatol; 2006 Aug; 18(8):895-9. PubMed ID: 16825909
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Abdelnaby H; Ndiaye NC; D'Amico F; Fouad AM; Hassan S; Elshafey A; Al Hashash W; Faisal M; Alshamali Y; Al-Taweel T; Peyrin-Biroulet L
    Saudi J Gastroenterol; 2021; 27(4):249-256. PubMed ID: 34341249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn's disease.
    Ferreira AC; Almeida S; Tavares M; Canedo P; Pereira F; Regalo G; Figueiredo C; Trindade E; Seruca R; Carneiro F; Amil J; Machado JC; Tavarela-Veloso F
    Inflamm Bowel Dis; 2005 Apr; 11(4):331-9. PubMed ID: 15803022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NOD2/CARD15 mutations on Crohn's disease phenotype in an Italian population.
    Bianchi V; Maconi G; Ardizzone S; Colombo E; Ferrara E; Russo A; Tenchini ML; Porro GB
    Eur J Gastroenterol Hepatol; 2007 Mar; 19(3):217-23. PubMed ID: 17301648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic susceptibility to increased bacterial translocation influences the response to biological therapy in patients with Crohn's disease.
    Gutiérrez A; Scharl M; Sempere L; Holler E; Zapater P; Almenta I; González-Navajas JM; Such J; Wiest R; Rogler G; Francés R
    Gut; 2014 Feb; 63(2):272-80. PubMed ID: 23376290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the NOD2 gene are associated with a specific phenotype and lower anti-tumor necrosis factor trough levels in Crohn's disease.
    Schäffler H; Geiss D; Gittel N; Rohde S; Huth A; Glass Ä; Brandhorst G; Jaster R; Lamprecht G
    J Dig Dis; 2018 Nov; 19(11):678-684. PubMed ID: 30284387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CARD15/NOD2 polymorphisms do not explain concordance of Crohn's disease in Swedish monozygotic twins.
    Halfvarson J; Bresso F; D'Amato M; Järnerot G; Pettersson S; Tysk C
    Dig Liver Dis; 2005 Oct; 37(10):768-72. PubMed ID: 16002353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common NOD2/CARD15 and TLR4 Polymorphisms Are Associated with Crohn's Disease Phenotypes in Southeastern Brazilians.
    Tolentino YF; Elia PP; Fogaça HS; Carneiro AJ; Zaltman C; Moura-Neto R; Luiz RR; Carvalho Mda G; de Souza HS
    Dig Dis Sci; 2016 Sep; 61(9):2636-47. PubMed ID: 27107867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NOD2/CARD15 gene variants are linked to failure of antibiotic treatment in perianal fistulating Crohn's disease.
    Angelberger S; Reinisch W; Dejaco C; Miehsler W; Waldhoer T; Wehkamp J; Lichtenberger C; Schaeffeler E; Vogelsang H; Schwab M; Teml A
    Am J Gastroenterol; 2008 May; 103(5):1197-202. PubMed ID: 18371140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.